BIP
AMPE

Brandes Investment Partners’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Brandes Investment Partners’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-167
Closed -$204K – 159
2017
Q4 		$204K Buy
+167
New +$78.5K ﹤0.01% 138

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Brandes Investment Partners's AMPE Position: Q1 2018 in Review

Brandes Investment Partners sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q1 2018, closing a stake of 167 shares — an estimated $204K sold.

Brandes Investment Partners first reported a position in AMPE in Q4 2017 and held it in 1 quarter. The position peaked at $204K in Q4 2017. 71 funds tracked by Wall St. Rank hold AMPE as of Q1 2018.

  • Brandes Investment Partners reported no remaining Ampio Pharmaceuticals Inc. position as of Q1 2018 after selling out during the quarter.
  • Brandes Investment Partners sold 167 Ampio Pharmaceuticals Inc. shares in Q1 2018, an estimated $204K.
  • Brandes Investment Partners first reported a position in Ampio Pharmaceuticals Inc. in Q4 2017 and held it in 1 quarter.
  • Brandes Investment Partners's Ampio Pharmaceuticals Inc. position peaked at $204K in Q4 2017.
  • 71 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q1 2018.

Based on Brandes Investment Partners's 13F filing for Q1 2018, filed 15 May 2018.